Skip to content
-
News |
03.26.26
— Zola® revenues increase 17% year-over-year — — Arcadia and Roosevelt Resources terminate proposed business combination — — Exercise of preferred investment options yields $2.1 million gross proceeds — DALLAS, Texas (March 26, 2026) – Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today released its financial and business results…Continue Reading »
-
News |
01.12.26
DALLAS, Texas (January 12, 2026) – Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today announced that it has entered into definitive agreements for the immediate exercise of certain outstanding preferred investment options to purchase up to an aggregate of 808,595 shares originally issued in December 2020, January 2021, August…Continue Reading »
-
News |
12.26.25
DALLAS, Texas (December 26, 2025) – Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today announced that on December 24, 2025, it received a notice from Roosevelt Resources, LP, terminating the Securities Exchange Agreement between Arcadia and Roosevelt dated December 4, 2024, pursuant to the terms of the agreement. The…Continue Reading »
-
News |
11.07.25
— Zola® year-to-date revenues increase 26% year over year — — Arcadia gross profit margins exceed 30% for 11th straight quarter — — Arcadia cash balance declines by only $257K to $1.1M — DALLAS, Texas (November 7, 2025) – Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today released its…Continue Reading »
-
News |
08.14.25
— Arcadia revenues increase 11% year over year driven by 24% growth in Zola® — — Arcadia receives 2.7 million shares of stock in ABVE — — Arcadia eliminates $1M in liabilities — DALLAS, Texas (August 14, 2025) – Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today released its…Continue Reading »
-
News |
05.08.25
— Revenues increase 22% year over year driven by 90% growth in Zola® — — Arcadia sells patents for $750K and eliminates $1M in liabilities — — Roosevelt agreement amended to provide greater certainty regarding exchange ratio — DALLAS, Texas (May 8, 2025) – Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative,…Continue Reading »
-
News |
04.29.25
Dallas, Texas (April 29, 2025) – Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the first quarter of 2025 on May 8, 2025. The company has scheduled a conference call for 2:00 p.m. Eastern time…Continue Reading »
-
News |
03.20.25
— Year-over-year revenues grew 56% in Q4 and 13% for full year — — Zola® year-over-year revenues increased 124% in Q4 and 46% for full year — — Company plans business combination with Roosevelt Resources, Inc. — DALLAS, Texas (March 20, 2025) – Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based…Continue Reading »
-
News |
03.06.25
DALLAS, Texas (March 6, 2025) – Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the fourth quarter and full year of 2024 after market close on March 20, 2025. The company has scheduled a conference…Continue Reading »
